Heidi Jacobson

Heidi is a Research Associate supporting the Global Equity Strategy at Axiom Investors. Prior to Axiom, Heidi was an Equity Research Associate on the Biopharma, Emerging Immunology, and Rare Disease teams at Leerink Partners. Heidi graduated from Harvard University and holds a B.A. in Integrative Biology. In her free time, Heidi enjoys training for athletic competitions, exploring New York City’s food scene, and spending time with friends and family.